Bradley BS - Ryan Specialty Chief Officer
| RYAN Stock | USD 63.99 0.41 0.64% |
Insider
Bradley BS is Chief Officer of Ryan Specialty Group
| Age | 58 |
| Address | 155 North Wacker Drive, Chicago, IL, United States, 60606 |
| Phone | 312 784 6001 |
| Web | https://www.ryanspecialty.com/ |
Ryan Specialty Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2407 %, meaning that it created $0.2407 on every $100 dollars invested by stockholders. Ryan Specialty's management efficiency ratios could be used to measure how well Ryan Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ryan Specialty's Return On Capital Employed is very stable compared to the past year. As of the 29th of December 2024, Return On Equity is likely to grow to 0.12, while Return On Tangible Assets are likely to drop 0.01. At this time, Ryan Specialty's Net Tangible Assets are very stable compared to the past year. As of the 29th of December 2024, Non Currrent Assets Other is likely to grow to about 57.1 M, while Total Assets are likely to drop about 5.7 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| Bradford Cowles | Core Main | 53 | |
| Fernando Blasco | Hayward Holdings | 45 | |
| Donald Smith | Hayward Holdings | 53 | |
| Lawrence Silber | Hayward Holdings | 64 | |
| Michael Colicchio | Hayward Holdings | 62 | |
| Mark Whittenburg | Core Main | 56 | |
| Greg Brenneman | Hayward Holdings | N/A | |
| Ian Rorick | Core Main | 32 | |
| John Warcop | Paycor HCM | N/A | |
| Jennifer Noonan | Core Main | N/A | |
| James Castellano | Core Main | 68 | |
| Robyn Bradbury | Core Main | N/A | |
| Kathleen Mazzarella | Core Main | 61 | |
| Jonathan Zrebiec | Core Main | 40 | |
| Kevin Brown | Hayward Holdings | 45 | |
| Arthur Soucy | Hayward Holdings | 57 | |
| Susan Canning | Hayward Holdings | 54 | |
| Laura Schneider | Core Main | 63 | |
| Mauro Stocchi | Stevanato Group SpA | 58 | |
| Marco Lago | Stevanato Group SpA | 51 | |
| Joe Meyer | Paycor HCM | N/A | |
Management Performance
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.0399 |
Ryan Specialty Group Leadership Team
Elected by the shareholders, the Ryan Specialty's board of directors comprises two types of representatives: Ryan Specialty inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryan. The board's role is to monitor Ryan Specialty's management team and ensure that shareholders' interests are well served. Ryan Specialty's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryan Specialty's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Vanacker, Chief Operating Officer, Executive Vice President | ||
| Patrick Ryan, Chairman of the Board of Directors, Chief Executive Officer, Founder | ||
| Mark Esq, General VP | ||
| Jeremiah Bickham, Chief Financial Officer, Executive Vice President | ||
| Alice Topping, Chief Officer | ||
| Brendan Mulshine, Executive Vice President Chief Revenue Officer | ||
| Kirk Behrens, Technology Operations | ||
| Lisa Paschal, Chief Human Resources Officer, Senior Vice President | ||
| Dawn DOnofrio, CorRisk, WKFC | ||
| Michael Ohalleran, Director | ||
| David Bolger, Independent Director | ||
| John Rogers, Independent Director | ||
| Mark Melander, Chief Officer | ||
| Andrew McKenna, Independent Director | ||
| Robert Blanc, Independent Director | ||
| Bradley BS, Chief Officer | ||
| William Devers, Independent Director | ||
| Nicholas CFA, Director Relations | ||
| Timothy Turner, President, Director, Chairman and Chief Executive Officer of RT Specialty | ||
| Nicholas Cortezi, Chairman - RSG Underwriting Managers | ||
| Henry Bienen, Independent Director | ||
| Mark Katz, Executive Vice President General Counsel | ||
| Noah Angeletti, Treasurer Relations | ||
| Kieran Dempsey, EVP Officer | ||
| Janice Hamilton, Chief Controller | ||
| Michael Blackshear, Chief VP | ||
| Jamie Bouloux, Chief Risk | ||
| D Findlay, Independent Director |
Ryan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ryan Specialty a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 10.62 B | ||||
| Shares Outstanding | 125.17 M | ||||
| Shares Owned By Insiders | 14.65 % | ||||
| Shares Owned By Institutions | 87.03 % | ||||
| Number Of Shares Shorted | 5.59 M | ||||
| Price To Earning | 82.48 X |
Pair Trading with Ryan Specialty
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ryan Specialty position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryan Specialty will appreciate offsetting losses from the drop in the long position's value.Moving against Ryan Stock
The ability to find closely correlated positions to Ryan Specialty could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryan Specialty when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryan Specialty - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryan Specialty Group to buy it.
The correlation of Ryan Specialty is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ryan Specialty moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ryan Specialty Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ryan Specialty can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.408 | Dividend Share 0.33 | Earnings Share 0.77 | Revenue Per Share 19.549 | Quarterly Revenue Growth 0.207 |
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.